Schwarz seeks new approval for Neupro

Schwarz Pharma has filed for European approval to sell its Neupro patch for advanced Parkinson's. Schwarz received an approval for Neupro as a therapy for early-stage Parkinson's early this year.

- check out the release on Neupro

Suggested Articles

NASH leaders weigh in on the need for a drug for the disease and the challenges in getting it to patients.

The $210 million fund began life by leading a $17 million series A round in Quellis Biosciences.

The nine-story building will house Amgen’s Bay Area employees when it opens early in 2022.